Usefulness of presepsin in predicting the prognosis of patients with sepsis or septic shock: a retrospective cohort study
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background: The diagnosis and prediction of prognosis are important in patients with sepsis, and presepsin is helpful. In this study, we aimed to examine the usefulness of presepsin in predicting the prognosis of sepsis in Korea. Methods: Patients diagnosed with sepsis according to the sepsis-3 criteria were recruited into the study and classified into surviving and non-surviving groups based on in-hospital mortality. A total of 153 patients (32 and 121 patients with sepsis and septic shock, respectively) were included from July 2019 to August 2020. Results: Among the 153 patients with sepsis, 91 and 62 were in the survivor and non-survivor groups, respectively. Presepsin (p=0.004) and lactate (p=0.003) levels and the sequential organ failure assessment (SOFA) score (p<0.001) were higher in the non-survivor group. Receiver operating characteristic curve analysis revealed poor performances of presepsin and lactate in predicting the prognosis of sepsis (presepsin: area under the curve [AUC]=0.656, p=0.001; lactate: AUC=0.646, p=0.003). The SOFA score showed the best performance, with the highest AUC value (AUC=0.751, p<0.001). The prognostic cutoff point for presepsin was 1,176 pg/mL. Presepsin levels higher than 1,176 pg/mL (odds ratio [OR], 3.352; p<0.001), higher lactate levels (OR, 1.203; p=0.003), and higher SOFA score (OR, 1.249; p<0.001) were risk factors for in-hospital mortality. Conclusion: Presepsin levels were higher in non-survivors than in survivors. Thus, presepsin may be a valuable biomarker in predicting the prognosis of sepsis.
Abstract
Background: The diagnosis and prediction of prognosis are important in patients with sepsis, and presepsin is helpful. In this study, we aimed to examine the usefulness of presepsin in predicting the prognosis of sepsis in Korea. Methods: Patients diagnosed with sepsis according to the sepsis-3 criteria were recruited into the study and classified into surviving and non-surviving groups based on in-hospital mortality. A total of 153 patients (32 and 121 patients with sepsis and septic shock, respectively) were included from July 2019 to August 2020. Results: Among the 153 patients with sepsis, 91 and 62 were in the survivor and non-survivor groups, respectively. Presepsin (p=0.004) and lactate (p=0.003) levels and the sequential organ failure assessment (SOFA) score (p<0.001) were higher in the non-survivor group. Receiver operating characteristic curve analysis revealed poor performances of presepsin and lactate in predicting the prognosis of sepsis (presepsin: area under the curve [AUC]=0.656, p=0.001; lactate: AUC=0.646, p=0.003). The SOFA score showed the best performance, with the highest AUC value (AUC=0.751, p<0.001). The prognostic cutoff point for presepsin was 1,176 pg/mL. Presepsin levels higher than 1,176 pg/mL (odds ratio [OR], 3.352; p<0.001), higher lactate levels (OR, 1.203; p=0.003), and higher SOFA score (OR, 1.249; p<0.001) were risk factors for in-hospital mortality. Conclusion: Presepsin levels were higher in non-survivors than in survivors. Thus, presepsin may be a valuable biomarker in predicting the prognosis of sepsis.
참고문헌 (30)
- Singer M, "The third international consensus definitions for sepsis and septic shock(Sepsis-3)", JAMA, 315, pp.801~810 (2016)
- Kim JH, "Influence of full-time intensivist and the nurse-to-patient ratio on the implementation of severe sepsis bundles in Korean intensive care units", J Crit Care, 27, pp.414~ (2012)
- 박대원, "Epidemiological and Clinical Characteristics of Community- Acquired Severe Sepsis and Septic Shock: A Prospective Observational Study in 12 University Hospitals in Korea", Journal of Korean Medical Science, 27(11), pp.1308~1314 (2012), 대한의학회
- Annane D, "Effects of fluid resuscitation with colloids vs crystalloids on mortality in critically ill patients presenting with hypovolemic shock : the CRISTAL randomized trial", JAMA, 310, pp.1809~1817 (2013)
- Rivers E, "Early goal-directed therapy in the treatment of severe sepsis and septic shock", N Engl J Med, 345, pp.1368~1377 (2001)
- Gaieski DF, "Benchmarking the incidence and mortality of severe sepsis in the United States", Crit Care Med, 41, pp.1167~1174 (2013)
- Kaukonen KM, "Mortality related to severe sepsis and septic shock among critically ill patients in Australia and New Zealand, 2000-2012", JAMA, 311, pp.1308~1316 (2014)
- Brodska H, "Diagnostic and prognostic value of presepsin vs. established biomarkers in critically ill patients with sepsis or systemic inflammatory response syndrome", Clin Chem Lab Med, 56, pp.658~668 (2018)
- Mihajlovic D, "Use of presepsin and procalcitonin for prediction of SeptiFast results in critically ill patients", J Crit Care, 40, pp.197~201 (2017)
- Kweon OJ, "Usefulness of presepsin(sCD14 subtype)measurements as a new marker for the diagnosis and prediction of disease severity of sepsis in the Korean population", J Crit Care, 29, pp.965~970 (2014)
- Zhang X, "The accuracy of presepsin(sCD14-ST)for the diagnosis of sepsis in adults : a meta-analysis", Crit Care, 19, pp.323~ (2015)
- Zou Q, "Presepsin as a novel sepsis biomarker", World J Emerg Med, 5, pp.16~19 (2014)
- Okamura Y, "Usefulness of presepsin measurement : a new biomarker for sepsis", Rinsho Byori, 63, pp.62~71 (2015)
- Zhang J, "Diagnostic value of presepsin for sepsis: a systematic review and meta-analysis", Medicine (Baltimore), 94, pp.e2158~ (2015)
- Hassan EA, "Clinical value of presepsin in comparison to hsCRP as a monitoring and early prognostic marker for sepsis in critically ill patients", Medicina(Kaunas), 55, pp.36~ (2019)
- Kondo Y, "Diagnostic value of procalcitonin and presepsin for sepsis in critically ill adult patients : a systematic review and meta-analysis", J Intensive Care, 7, pp.22~ (2019)
- Ali FT, "Presepsin is an early monitoring biomarker for predicting clinical outcome in patients with sepsis", Clin Chim Acta, 460, pp.93~101 (2016)
- Wen MY, "Presepsin level in predicting patients’ in-hospital mortality from sepsis under sepsis-3 criteria", Ther Clin Risk Manag, 15, pp.733~739 (2019)
- Yang HS, "Prognostic value of presepsin in adult patients with sepsis : systematic review and meta-analysis", PLoS One, 13, pp.e0191486~ (2018)
- Yunus I, "The use of procalcitonin in the determination of severity of sepsis, patient outcomes and infection characteristics", PLoS One, 13, pp.e0206527~ (2018)
- 유승목, "Utility of the early lactate area score as a prognostic marker for septic shock patients in the emergency department", Acute and Critical Care, 34(2), pp.126~132 (2019), 대한중환자의학회[DOI]
- Larsen FF, "Novel biomarkers for sepsis : a narrative review", Eur J Intern Med, 45, pp.46~50 (2017)
- Zhang Y, "Diagnostic and predictive performance of biomarkers in patients with sepsis in an intensive care unit", J Int Med Res, 47, pp.44~58 (2019)
- Giavarina D, "Determination of reference interval for presepsin, an early marker for sepsis", Biochem Med(Zagreb), 25, pp.64~68 (2015)
- Jereb M, "Usefulness of presepsin as diagnostic and prognostic marker of sepsis in daily clinical practice", J Infect Dev Ctries, 13, pp.1038~1044 (2019)
- Masson S, "Presepsin(soluble CD14 subtype)and procalcitonin levels for mortality prediction in sepsis : data from the Albumin Italian Outcome Sepsis trial", Crit Care, 18, pp.R6~ (2014)
- Liu B, "Diagnostic value and prognostic evaluation of Presepsin for sepsis in an emergency department", Crit Care, 17, pp.R244~ (2013)
- Kim H, "Multi-marker approach using procalcitonin, presepsin, galectin-3, and soluble suppression of tumorigenicity 2 for the prediction of mortality in sepsis", Ann Intensive Care, 7, pp.27~ (2017)
- Carpio R, "Utility of presepsin(sCD14-ST)as a diagnostic and prognostic marker of sepsis in the emergency department", Clin Chim Acta, 450, pp.169~175 (2015)
- Zhu Y, "The accuracy assessment of presepsin(sCD14-ST)for mortality prediction in adult patients with sepsis and a head-to-head comparison to PCT : a meta-analysis", Ther Clin Risk Manag, 15, pp.741~753 (2019)